Fulminant hepatic failure in acute hepatitis C: Increased risk in chronic carriers of hepatitis B virus

Gut

Volumn 45, Issue 4, 1999, Pages 613-617

  Chu, C M ^a   Yeh, C T ^a   Liaw, Y F ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Acute hepatitis C; Fulminant hepatitis; Hepatitis B virus; Hepatitis C virus; Hepatitis G virus

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; GLOBULIN; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; VIRUS RNA;

ADULT; ARTICLE; DISEASE CARRIER; ENZYME IMMUNOASSAY; FEMALE; GENOTYPE; HEPATITIS B; HEPATITIS C; HEPATITIS G VIRUS; HUMAN; INCIDENCE; LIVER FAILURE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIOIMMUNOASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK; SERODIAGNOSIS;

EID: 0032835069     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.45.4.613     Document Type: Article

References (29)

1. O'Grady JG, Schalm SW, Williams R. Acute liver failure: redefining the syndromes. Lancet 1993;342:273-5.
2. Bernuau J, Rueff B, Benhamou JP. Fulminant and subfulminant liver failure: definitions and causes. Semin Liver Dis 1986;6:97-106.
3. Kuo G, Choo QL, Alters HJ, et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989;244;362-4.
4. Wright TL, Mamish D, Combs C, et al. Hepatitis B virus and apparent fulminant non-A, non-B hepatitis. Lancet 1992;339:952-5.
5. Liang TJ, Jeffers L, Reddy RK, et al. Fulminant or subfulminant non-A, non-B viral hepatitis: the role of hepatitis C and E viruses. Gastroenterology 1993;104:556-62.
6. Féray C, Gigou M, Samuel D, et al. Hepatitis C virus RNA and hepatitis B virus DNA in serum and liver of patients with fulminant hepatitis. Gastroenterology 1993;104:549-55.
7. Theilmann L, Sobach C, Toex U, et al. Role of hepatitis C virus infection in German patients with fulminant and subacute hepatic failure. Eur J Clin Invest 1992;22:569-71.
8. Sallie R, Silva AE, Purdy M, et al. Hepatitis C and E in non-A non-B fulminant hepatic failure: a polymerase chain reaction and serological study. J Hepatol 1994;20:580-8.
9. Yanagi M, Kaneko S, Unoura M, et al. Hepatitis C virus in fulminant hepatic failure [letter]. N Engl J Med 1991;324:1895-6.
10. Chu CM, Sheen IS, Liaw YF. The role of hepatitis C virus in fulminant viral hepatitis in an area with endemic hepatitis A and B. Gastroenterology 1994;107:189-95.
11. Takada N, Takase S, Takada A, et al. Differences in the hepatitis C virus genotypes in different countries. J Hepatol 1993;17:277-83.
12. Dawson GJ, Shlauder GG, Pilat-Matias TJ, et al. Prevalence of GB virus-C infection using reverse transcriptase-polymerase chain reaction. J Med Virol 1996;50:97-103.
13. Chu CM, Liaw YF, Yang CY, et al. Diagnosis of acute type B hepatitis by a solid phase u-antibody capture radioimmunoassay for IgM class antibody to hepatitis B core antigen: a diagnostic proposal based on a prospective study. Liver 1987;7:182-7.
14. Alter MJ, Margolis HS, Krawtzynski K, et al. The natural history of community acquired hepatitis C in the United States. N Engl J Med 1992;327:1899-905.
15. Chu CM, Karayiannis P, Fowler MJF, et al. Natural history of chronic hepatitis B virus infection in Taiwan: studies of hepatitis B virus DNA in serum. Hepatology 1985;5:431-4.
16. Yeh CT, Shyu WC, Sheen IS, et al. Quantitative assessment of hepatitis C virus RNA by polymerase chain reaction and a digoxigenin detection system: comparison between branched DNA assay. J Virol Methods 1997;65:219-26.
17. Kao JH, Chen PJ, Chen W, et al. Amplification of GB virus-C/hepatitis G virus RNA with primers from different regions of the viral genome. J Med Virol 1997;51:284-9.
18. Wu JS, Chen CH, Chiang YH, et al. Hepatitis A virus in Taiwan. J Formos Med Assoc 1980;79:694-9.
19. Sung JL, Chen DS, Lai MY, et al. Epidemiological study on hepatitis B virus infection in Taiwan. Chinese Journal of Gastroenterology 1984;1:1-9.
20. Chu CM, Sheen IS, Liaw YF. The etiology of acute hepatitis in Taiwan: acute hepatitis superimposed on HBsAg carrier state as the main etiology of acute hepatitis in areas with high HBsAg carrier state. Infection 1988;16:233-7.
21. Papalvangelou G, Tassopoulos N, Roumeliotou-Karayannis A, et al. Etiology of fulminant viral hepatitis in Greece. Hepatology 1984;4:369-72.
22. Chu CM, Liaw YF. The incidence of fulminant hepatic failure in acute viral hepatitis in Taiwan: increased risk in patients with pre-existing HBsAg carrier state. Infection 1990;18:200-3.
23. Dienstag JL. Non-A, non-B hepatitis. I. Recognition, epidemiology, and clinical features. Gastroenterology 1983;85:439-62.
24. Keeffe EB. Is hepatitis A more severe in patients with chronic hepatitis B and other chronic liver diseases. Am J Gastroenterol 1995;90:201-5.
25. Vento S, Garofano T, Renzini C, et al. Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C. N Engl J Med 1998;338:286-90.
26. Trey C, Davidson C. The management of fulminant hepatic failure. Prog Liver Dis 1970;3:282-98.
27. Dudley F, Fox J, Sherlock RA. Cellular immunity and hepatitis associard (Australia) antigen liver disease. Lancet 1972;i:743-6.
28. Chu CM, Liaw YF. Peripheral T-cell subsets in asymptomatic hepatitis B virus carriers. Cell Immunol 1986;98:533-7.
29. Ikeda T, Lever AML, Thomas HC. Evidence for a deficiency of interferon production in patients with chronic hepatitis B virus infection acquired in adult life. Hepatology 1986;6:962-5.